Biotechnology manufacturer
Regulatory and reimbursement policy issues related to federal healthcare programs, including Medicare and Medicaid.
Medicare reimbursement for transformative therapies. 
H.R. 1409, the "Cancer Drug Parity Act". 
H.R. 2051, the "FAST Generics Act".
H.R. 2077, the "Restoring the Patient's Voice Act".
HCR - Health Issues
2 - HOUSE OF REPRESENTATIVES 1 - SENATE
BAKER & HOSTETLER LLP
1050 Connecticut Ave NW Suite 1100, Washington, DC, 20036, US
CHRIS JONES ADAM HIGGINS TYLER THOMPSON